Phase IB study of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors.
Osama E RahmaKevin TyanAnita Giobbie-HurderAndrew S BrohlPhilippe L BedardDaniel J RenoufElad SharonHoward StreicherEmma HathawayRachel CunninghamMichael ManosMariano SevergniniScott RodigF Stephen HodiPublished in: Journal for immunotherapy of cancer (2022)
NCT02298959.